Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026)
Revvity's (RVTY) quarterly Depreciation & Amortization (CF) came in at $105.1 million in Q2 2026, up 7.84% YoY from $97.4 million in Q2 2025, and up 1.92% on a QoQ basis from $103.1 million in Q4 2025.
Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $105.1 million in Q2 2026.
- Quarterly Depreciation & Amortization (CF) rose 7.84% year-over-year to $105.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $413.0 million (down 1.08% YoY) and the FY2025 annual result came in at $405.3 million, down 5.26% from the prior year.
- Depreciation & Amortization (CF) grew to $105.1 million in Q2 2026, from $103.1 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $229.6 million in Q1 2023 to a low of $97.4 million in Q1 2025.
- A 5-year average of $113.9 million and a median of $107.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 55.77% — and 2023, when it slumped 54.02%.
- Tracing RVTY's Depreciation & Amortization (CF) over 5 years: stood at $109.3 million in 2022, then slipped by 3.44% to $105.6 million in 2023, then decreased by 0.51% to $105.0 million in 2024, then dropped by 1.86% to $103.1 million in 2025, then increased by 1.92% to $105.1 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $105.1 million (Q2 2026), $103.1 million (Q4 2025), and $102.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.48 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 41.05 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 179.00 Mn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 102.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 102.04 Mn |
| Jul 5, 2026 | 102.04 Mn |
| Apr 5, 2026 | 105.06 Mn |
| Apr 5, 2026 | 105.06 Mn |
| Dec 28, 2025 | 103.08 Mn |
| Dec 28, 2025 | 103.08 Mn |
| Sep 28, 2025 | 102.06 Mn |
| Sep 28, 2025 | 102.06 Mn |
| Jun 29, 2025 | 102.78 Mn |
| Jun 29, 2025 | 102.78 Mn |
| Mar 30, 2025 | 97.42 Mn |
| Mar 30, 2025 | 97.42 Mn |
| Dec 29, 2024 | 105.03 Mn |
| Dec 29, 2024 | 105.03 Mn |
| Sep 29, 2024 | 107.67 Mn |
| Sep 29, 2024 | 107.67 Mn |
| Jun 30, 2024 | 107.34 Mn |
| Jun 30, 2024 | 107.34 Mn |
| Mar 31, 2024 | 107.80 Mn |
| Mar 31, 2024 | 107.80 Mn |